Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Nitrosamines – Strategic Consultancy

We offer services to provide the necessary expertise and strategy to establish a robust background and compliance framework to be compliant with the ICH M7 definitions and FDA requirements. This includes the creation of necessary SOPs to nitrosamine risk assessment and mitigation, or evaluation of existing processes to identify areas for improvement.

Attractive female scientist testing using beaker and peppet in labratory

Development of Background

We work closely with clients to develop a comprehensive documentation framework customized to their specific needs and compliance requirements. This includes the creation of SOPs, work instructions, and protocols for conducting risk assessments, sampling plans, and analytical testing methods for nitrosamine detection. We also assist in drafting guidance documents and templates to streamline the documentation process and ensure consistency across departments and facilities.

GAP Analysis and Process Evaluation

Our experts conduct a thorough evaluation of existing processes, including manufacturing, testing, and quality control procedures, to identify potential sources of nitrosamine contamination. We assess the adequacy of current risk assessment methodologies and control measures in place to mitigate nitrosamine-related risks. Based on the findings, we provide detailed recommendations for process improvements and updates to documentation, such as SOPs and risk management plans.

Strategy Development and Implementation Plan

Our team collaborates with clients to develop a strategic roadmap for achieving and maintaining compliance with ICH M7 guidelines. We help define short-term and long-term goals, establish key performance indicators (KPIs), and develop an actionable implementation plan. This may involve identifying training needs, establishing communication channels, and allocating resources effectively to support ongoing compliance efforts.

Close-up of a scientist in protective suit analyzing pills in the laboratory

Nitrosamines – Strategy
Definition

Pink pills in a white jar. Pills on white background

Nitrosamines – Data Management Strategy Creation

Asian scientist biochemist or microbiologist working research with a microscope in laboratory.

Nitrosamines – Drug Product Risk Management Strategy Creation

Doctor, hands and vaccine bottle with injection for medicine, safety and healthcare risk in clinic.

Nitrosamines – Drug Substance Risk Management Strategy Creation (for NDSRI)

Female lab tech takes sample from test tube to research material at workplace with modern equipment

Nitrosamines – GAP Assessment regarding ICH M7

Woman holding research at the laboratory

Nitrosamines – Analytical Strategy Creation

Customized support for Nitrosamines Compliance

Our strategic approach to ensure Nitrosamine compliance is based on global and holistic experience, and can be perfectly adapted to your reality. We address the latest regulations and risk assessments, helping you manage and mitigate potential risks specific to your products and processes.

Why Zamann?

Zamann stays ahead of the evolving Nitrosamine requirements, providing expert guidance to ensure compliance with confidence. Our proactive and senior approach helps protect product integrity and patient safety, securing your operations against regulatory risks.

Modern Laboratory Work Space

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

Our Customers